Human hepatitis B virus (HBV) is a cause of both acute and chronic liver disease in man, and chronic infections are epidemiologically associated with hepatocellular carcinoma. HBV is the prototype of a new family of hepatotropic DNA viruses (hepadna viruses) which includes woodchuck hepatitis virus, ground squirrel hepatitis virus, and duck hepatitis B virus (DHBV). Our recent studies with DHBV indicate a novel mode of replication for the hepadna viruses, involving reverse transcription of an RNA intermediate occurring as a step in virion maturation. The long term objective in studying the hepadna viruses is to understand and prevent the phenomenon of viral pathogenesis. An important aspect of this problem is to understand the molecular biology of virus replication, including the mechanism of initiation of infection and the control of virus expression. We have been studying these processes using DHBV as a model of human hepatitis B virus. During the next three years, our main objectives will be in two areas. First, we propose to characterize in detail the initiation of infection in embryos and ducklings, and the basis for the age dependent decline in susceptibility. Second, we will continue work on the mechanism of virus DNA synthesis, including the structure of the RNA template for minus strand synthesis and the DNA template for plus strand synthesis, and the mechanisms and timing for initiation and elongation of both strands. As a new area of research in our lab, we will also carry out a pilot project on the induction and role of liver specific immunoregulatory factors in viral hepatitis in Pekin ducks. Towards these goals, we have demonstrated that infection is rapid (less than 24h) in embryos and young ducklings, allowing a detailed characterization of early steps in infection without recourse to tissue culture systems, which are unavailable. In addition, DNA synthesis complexes are readily isolated from the liver, permitting analysis of virion DNA synthesis in an in vitro system. Cloned DNA as well as antibodies have been prepared to assist both studies, and we have been able to use the former to identify the origin and a potential primer (protein) of reverse transcription.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
2R01AI018641-04
Application #
3128080
Study Section
Virology Study Section (VR)
Project Start
1982-09-01
Project End
1989-08-31
Budget Start
1985-09-01
Budget End
1986-08-31
Support Year
4
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Institute for Cancer Research
Department
Type
DUNS #
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Cai, Dawei; Mills, Courtney; Yu, Wenquan et al. (2012) Identification of disubstituted sulfonamide compounds as specific inhibitors of hepatitis B virus covalently closed circular DNA formation. Antimicrob Agents Chemother 56:4277-88
Mason, William S; Liu, Chen; Aldrich, Carol E et al. (2010) Clonal expansion of normal-appearing human hepatocytes during chronic hepatitis B virus infection. J Virol 84:8308-15
Mason, William S; Low, Huey-Chi; Xu, Chunxiao et al. (2009) Detection of clonally expanded hepatocytes in chimpanzees with chronic hepatitis B virus infection. J Virol 83:8396-408
Mason, William S; Xu, Chunxiao; Low, Huey Chi et al. (2009) The amount of hepatocyte turnover that occurred during resolution of transient hepadnavirus infections was lower when virus replication was inhibited with entecavir. J Virol 83:1778-89
Mason, W S; Litwin, S; Xu, C et al. (2007) Hepatocyte turnover in transient and chronic hepadnavirus infections. J Viral Hepat 14 Suppl 1:22-8
Xu, Chunxiao; Yamamoto, Toshiki; Zhou, Tianlun et al. (2007) The liver of woodchucks chronically infected with the woodchuck hepatitis virus contains foci of virus core antigen-negative hepatocytes with both altered and normal morphology. Virology 359:283-94
Guo, Haitao; Mason, William S; Aldrich, Carol E et al. (2005) Identification and characterization of avihepadnaviruses isolated from exotic anseriformes maintained in captivity. J Virol 79:2729-42
Yamamoto, Toshiki; Litwin, Samuel; Zhou, Tianlun et al. (2002) Mutations of the woodchuck hepatitis virus polymerase gene that confer resistance to lamivudine and 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil. J Virol 76:1213-23
Zhu, Y; Yamamoto, T; Cullen, J et al. (2001) Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis. J Virol 75:311-22
Zhou, T; Saputelli, J; Aldrich, C E et al. (1999) Emergence of drug-resistant populations of woodchuck hepatitis virus in woodchucks treated with the antiviral nucleoside lamivudine. Antimicrob Agents Chemother 43:1947-54

Showing the most recent 10 out of 45 publications